Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents

Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents

Antibiotic resistance threatens effective treatment of microbial infections globally. This situation has spurred the hunt for new antimicrobial compounds in both academia and the pharmaceutical industry. Here, we report how the widely used antitumor drug cisplatin may be repurposed as an effective a...

Full description

Bibliographic Details
Main Authors: Yuan, Mingjun, Chua, Song Lin, Liu, Yang, Drautz-Moses, Daniela Isabel, Yam, Joey Kuok Hoong, Aung, Thet Tun, Beuerman, Roger W., Salido, May Margarette Santillan, Schuster, Stephan Christoph, Tan, Choon-Hong, Givskov, Michael, Yang, Liang, Nielsen, Thomas Eiland
Other Authors: School of Biological Sciences
Format: Journal Article
Language:English
Published: 2019
Subjects:
Cisplatin
DRNTU::Science::Biological sciences
Biofilm
Online Access:https://hdl.handle.net/10356/105980
http://hdl.handle.net/10220/47416

Internet

https://hdl.handle.net/10356/105980
http://hdl.handle.net/10220/47416

Similar Items